Drug Development Against Metastatic Cancers - Wikidata - awgldk - TriplyDB

Drug Development Against Metastatic Cancers

Drug Development Against Metastatic Cancers

http://www.wikidata.org/entity/Q38737865

about

Assessment of in vitro cytotoxic and genotoxic activities of some trimethoprim conjugates.

P2860

Q48239016-F9690477-07F2-4D3D-98D0-987B994C95FF

P2860

Drug Development Against Metastatic Cancers

http://www.wikidata.org/entity/Q38737865

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Drug Development Against Metastatic Cancers

@en

type

label

Drug Development Against Metastatic Cancers

@en

prefLabel

Drug Development Against Metastatic Cancers

@en

P1433

Q38737865-5CDB703A-28AC-4610-98A4-03B7CA5D8D68

P1476

Q38737865-08AABCB8-CD10-45C4-82C8-B6C8F1E19B6C

P2093

Q38737865-45A6F32E-EDDE-475A-8811-2AD4F8D1905A

Q38737865-8BE9BBFC-2D79-4C2C-AE34-636BB7762C46

P275

Q38737865-8450E79D-21D8-4AF0-BD9C-9C0114E4622E

P2860

Q38737865-025CC648-2DE9-4064-8A23-E879B9C7C619

Q38737865-037FE77D-DDD3-4BF4-9411-3E563EBC6FB8

Q38737865-19BC966B-873B-4ACE-8A34-CEA8B3278F56

Q38737865-1B39C67C-6777-4321-8EF7-1E8DCB64912C

Q38737865-28F09CB0-2DC5-4180-91E4-01C14A2268D0

Q38737865-2D80B96E-B822-4955-9344-0A29942D6D2A

Q38737865-300E0791-1D93-4596-9E22-0BE75E231787

Q38737865-3C876B73-D33D-4B2A-8E26-A78D4373AECC

Q38737865-517EC42C-92D9-46EB-B0DE-00AF8777C4C9

Q38737865-527C53DF-4100-48BE-B19F-6042010D6027

P304

Q38737865-324D2CEA-A9D4-4FA9-B517-AED87678D8CF

P31

Q38737865-02FFFDE6-6D99-48B6-99D2-09097FBF71D6

Q38737865-AFC24ABC-6F2A-4566-B5CB-BB2DE9166183

P433

Q38737865-11D11356-B7DB-4BAB-850C-5D66BA3B72BC

P478

Q38737865-767EAD7D-F521-4D24-8269-0EC076C6815F

P5008

Q38737865-3897B1D8-4DF4-4DD7-97DB-0074C6498491

P577

Q38737865-39BCFF71-C2CD-4D3A-A7E0-C59CF6F84EA9

Q38737865-857FF29B-A72B-40CA-950D-DE78FCB56BD9

P698

Q38737865-7F9256EB-8E18-4955-9334-981F18084C1A

P921

Q38737865-FD436285-5730-4793-9DE2-EC7DFF278F85

P932

Q38737865-DFF5969A-7651-4D2D-BFBC-4B15876D3243

P1433

Yale Journal of Biology and Medicine

P1476

Drug Development Against Metastatic Cancers

@en

P2093

Chen Wang

http://www.w3.org/2001/XMLSchema#string

Sui Huang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Cancer genome landscapes

Oncogenes and Cancer

Multiplex genome engineering using CRISPR/Cas systems

Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system

Cancer chemotherapy--the first twenty-five years

Breast Cancer Cell Invasion into a Three Dimensional Tumor-Stroma Microenvironment.

Tumor angiogenesis: therapeutic implications

Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence

Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards

Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disor

P304

119-123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28356899

http://www.w3.org/2001/XMLSchema#string

P921

P932

5369029

http://www.w3.org/2001/XMLSchema#string